CN104592367A - 流感病毒np蛋白突变体及其编码基因与应用 - Google Patents
流感病毒np蛋白突变体及其编码基因与应用 Download PDFInfo
- Publication number
- CN104592367A CN104592367A CN201410817649.2A CN201410817649A CN104592367A CN 104592367 A CN104592367 A CN 104592367A CN 201410817649 A CN201410817649 A CN 201410817649A CN 104592367 A CN104592367 A CN 104592367A
- Authority
- CN
- China
- Prior art keywords
- phh21
- sequence
- influenza virus
- restriction
- wsn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
重复1 | 重复2 | 重复3 | 平均值±标准差 | |
野生型 | 5.00 | 5.01 | 5.23 | 5.08±0.13 |
突变型 | 5.80 | 5.61 | 5.70 | 5.70±0.09 |
组别 | 第一组 | 第二组 | 第三组 |
小鼠死亡率(%) | 100% | 25% | 0 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410817649.2A CN104592367B (zh) | 2014-12-24 | 2014-12-24 | 流感病毒np蛋白突变体及其编码基因与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410817649.2A CN104592367B (zh) | 2014-12-24 | 2014-12-24 | 流感病毒np蛋白突变体及其编码基因与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104592367A true CN104592367A (zh) | 2015-05-06 |
CN104592367B CN104592367B (zh) | 2019-01-18 |
Family
ID=53118457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410817649.2A Active CN104592367B (zh) | 2014-12-24 | 2014-12-24 | 流感病毒np蛋白突变体及其编码基因与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104592367B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106834238A (zh) * | 2017-01-16 | 2017-06-13 | 中国科学院微生物研究所 | A型流感病毒温度敏感性的关键磷酸化位点及其应用 |
CN109966497A (zh) * | 2019-04-08 | 2019-07-05 | 中国医学科学院医药生物技术研究所 | 以ipan或其编码基因为靶点的物质在制备流感病毒抑制剂中的应用 |
CN111363017A (zh) * | 2018-12-25 | 2020-07-03 | 中国科学院微生物研究所 | A型流感病毒核蛋白s69位突变序列及其突变体与应用 |
CN112708601B (zh) * | 2019-10-24 | 2023-08-18 | 上海市农业科学院 | H1n1猪流感病毒ns1蛋白磷酸化位点丢失病毒的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102304495A (zh) * | 2011-09-08 | 2012-01-04 | 中国农业科学院上海兽医研究所 | 高效表达ha蛋白的重组流感病毒及其制备方法和应用 |
CN102839160A (zh) * | 2011-09-08 | 2012-12-26 | 中国农业科学院上海兽医研究所 | 高效表达ha蛋白的重组流感病毒及其制备方法和应用 |
CN103540613A (zh) * | 2002-04-26 | 2014-01-29 | 米迪缪尼有限公司 | 制备流感病毒的多质粒系统 |
CN104073513A (zh) * | 2013-03-25 | 2014-10-01 | 中国科学院上海巴斯德研究所 | 甲型流感病毒疫苗哺乳动物细胞适应株的获得方法和适应位点 |
-
2014
- 2014-12-24 CN CN201410817649.2A patent/CN104592367B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103540613A (zh) * | 2002-04-26 | 2014-01-29 | 米迪缪尼有限公司 | 制备流感病毒的多质粒系统 |
CN102304495A (zh) * | 2011-09-08 | 2012-01-04 | 中国农业科学院上海兽医研究所 | 高效表达ha蛋白的重组流感病毒及其制备方法和应用 |
CN102839160A (zh) * | 2011-09-08 | 2012-12-26 | 中国农业科学院上海兽医研究所 | 高效表达ha蛋白的重组流感病毒及其制备方法和应用 |
CN104073513A (zh) * | 2013-03-25 | 2014-10-01 | 中国科学院上海巴斯德研究所 | 甲型流感病毒疫苗哺乳动物细胞适应株的获得方法和适应位点 |
Non-Patent Citations (3)
Title |
---|
KRISTY M. BIALAS等: "Specific Nucleoprotein Residues Affect Influenza Virus Morphology", 《JOURNAL OF VIROLOGY》 * |
ZEJUN LI等: "Mutational Analysis of Conserved Amino Acids in the Influenza A Virus Nucleoprotein", 《JOURNAL OF VIROLOGY》 * |
王朝霞等: "PR8流感病毒突变株的制备及其在鸡胚上生长特性的研究", 《中国兽医科学》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106834238A (zh) * | 2017-01-16 | 2017-06-13 | 中国科学院微生物研究所 | A型流感病毒温度敏感性的关键磷酸化位点及其应用 |
WO2018129767A1 (zh) * | 2017-01-16 | 2018-07-19 | 中国科学院微生物研究所 | A型流感病毒温度敏感性的关键磷酸化位点及其应用 |
US10538745B2 (en) | 2017-01-16 | 2020-01-21 | Institute Of Microbiology, Chinese Academy Of Sciences | Key phosphorylation site of temperature sensitivity of influenza A virus and use thereof |
CN106834238B (zh) * | 2017-01-16 | 2020-04-14 | 中国科学院微生物研究所 | A型流感病毒温度敏感性的关键磷酸化位点及其应用 |
CN111363017A (zh) * | 2018-12-25 | 2020-07-03 | 中国科学院微生物研究所 | A型流感病毒核蛋白s69位突变序列及其突变体与应用 |
CN111363017B (zh) * | 2018-12-25 | 2022-03-15 | 中国科学院微生物研究所 | A型流感病毒核蛋白s69位突变序列及其突变体与应用 |
CN109966497A (zh) * | 2019-04-08 | 2019-07-05 | 中国医学科学院医药生物技术研究所 | 以ipan或其编码基因为靶点的物质在制备流感病毒抑制剂中的应用 |
CN109966497B (zh) * | 2019-04-08 | 2021-03-12 | 中国医学科学院医药生物技术研究所 | 以ipan或其编码基因为靶点的物质在制备流感病毒抑制剂中的应用 |
CN112708601B (zh) * | 2019-10-24 | 2023-08-18 | 上海市农业科学院 | H1n1猪流感病毒ns1蛋白磷酸化位点丢失病毒的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104592367B (zh) | 2019-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Phylogenetic and pathotypical analysis of two virulent Newcastle disease viruses isolated from domestic ducks in China | |
Dortmans et al. | Passaging of a Newcastle disease virus pigeon variant in chickens results in selection of viruses with mutations in the polymerase complex enhancing virus replication and virulence | |
Hulse-Post et al. | Molecular changes in the polymerase genes (PA and PB1) associated with high pathogenicity of H5N1 influenza virus in mallard ducks | |
Zhou et al. | The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus | |
Tada et al. | NP body domain and PB2 contribute to increased virulence of H5N1 highly pathogenic avian influenza viruses in chickens | |
Thampaisarn et al. | Characterization of avian paramyxovirus serotype 14, a novel serotype, isolated from a duck fecal sample in Japan | |
Kaplan et al. | Novel highly pathogenic avian A (H5N2) and A (H5N8) influenza viruses of clade 2.3. 4.4 from North America have limited capacity for replication and transmission in mammals | |
Feng et al. | Equine and canine influenza H3N8 viruses show minimal biological differences despite phylogenetic divergence | |
Selim et al. | Molecular characterization of full fusion protein (F) of Newcastle disease virus genotype VIId isolated from Egypt during 2012-2016 | |
CN101253267A (zh) | 用于犬科动物中呼吸系统疾病控制的物质和方法 | |
Baumann et al. | H1N1 swine influenza viruses differ from avian precursors by a higher pH optimum of membrane fusion | |
Choi et al. | Genetic relationship of H3 subtype avian influenza viruses isolated from domestic ducks and wild birds in Korea and their pathogenic potential in chickens and ducks | |
Zhu et al. | Mammalian-adaptive mutation NP-Q357K in Eurasian H1N1 swine influenza viruses determines the virulence phenotype in mice | |
Römer-Oberdörfer et al. | Enhancement of pathogenicity of Newcastle disease virus by alteration of specific amino acid residues in the surface glycoproteins F and HN | |
CN104592367A (zh) | 流感病毒np蛋白突变体及其编码基因与应用 | |
Tada et al. | Emergence of avian influenza viruses with enhanced transcription activity by a single amino acid substitution in the nucleoprotein during replication in chicken brains | |
Evseev et al. | Molecular evolution of the influenza A virus non-structural protein 1 in interspecies transmission and adaptation | |
Aouini et al. | Viral interference between low pathogenic avian influenza H9N2 and avian infectious bronchitis viruses in vitro and in ovo | |
Pascua et al. | Emergence of H3N2pM‐like and novel reassortant H3N1 swine viruses possessing segments derived from the A (H1N1) pdm09 influenza virus, Korea | |
Cai et al. | Molecular evolution of H1N1 swine influenza in Guangdong, China, 2016–2017 | |
Tsunekuni et al. | Recombinant avian paramyxovirus serotypes 2, 6, and 10 as vaccine vectors for highly pathogenic avian influenza in chickens with antibodies against Newcastle disease virus | |
Youk et al. | Mutations in PB1, NP, HA, and NA contribute to increased virus fitness of H5N2 highly pathogenic avian influenza virus clade 2.3. 4.4 in chickens | |
Kim et al. | Pathogenic assessment of avian influenza viruses in migratory birds | |
Liu et al. | Genotypic and pathotypic characterization of Newcastle disease virus isolated from racing pigeons in China | |
Zhang et al. | Tissue tropisms of avian influenza A viruses affect their spillovers from wild birds to pigs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Wenjun Inventor after: Li Jing Inventor after: Dong Xiukai Inventor after: Zheng Weinan Inventor after: Fan Wenhui Inventor after: Zhang Shuang Inventor after: Li Yun Inventor before: Liu Wenjun Inventor before: Li Jing Inventor before: Zheng Weinan Inventor before: Fan Wenhui Inventor before: Zhang Shuang Inventor before: Li Yun |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20171127 Address after: 100101 Beichen West Road, Beijing, No. 1 hospital, No. 2, No. Applicant after: Institute of Microbiology, Chinese Academy of Sciences Applicant after: DALIAN JINXIU BIOTECHNOLOGY ENGINEERING CO., LTD. Address before: 100101 Beichen West Road, Beijing, No. 1 hospital, No. 3, No. Applicant before: Institute of Microbiology, Chinese Academy of Sciences |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181212 Address after: No. 3, No. 1, Beichen West Road, Beichen, Beijing Applicant after: Institute of Microbiology, Chinese Academy of Sciences Applicant after: DALIAN JINXIU BIOTECHNOLOGY ENGINEERING CO., LTD. Applicant after: Dalian Huayuankou Economic Zone Animal Health Supervision Institute Applicant after: Panshan Animal Epidemic Prevention and Control Center Address before: No. 2, No. 1, Beichen West Road, Beichen, Beijing Applicant before: Institute of Microbiology, Chinese Academy of Sciences Applicant before: DALIAN JINXIU BIOTECHNOLOGY ENGINEERING CO., LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |